Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

Wide Spectrum Micronutrients Supplementation in Patients With Cancer Related Fatigue During Neoadjuvant and Adjuvant Chemotherapy

← catalyst calendar

NCT06137833

Sponsored by Pharmanutra S.p.a. (industry) · PHN.MI — their whole pipeline →. With Latis S.r.l..

Phase
Not applicable
Status
Recruiting
Study type
Interventional
Design
Randomized · Triple · Supportive care
Enrollment
92estimated
Sites
5
Country
Italy

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2023-11-27actualWhen the study began enrolling
Primary completion2025-12-31estimatedThe date the last participant is measured for the primary outcome — the readout window
Study completion2025-12-31estimatedThe whole study's end, after follow-up
First posted2023-11-18actualWhen this record first appeared on the registry
Results postedWhen the sponsor posted results to the registry
Record updated2025-10-01actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Conditions

  • Fatigue
  • Breast Cancer

Interventions

  • Dietary supplement: APPOPRTAL®
  • Other: Placebo

Primary outcome

what the primary-completion date above is the date OF
The change of fatigue perception by the patient through the BFI questionnaire
measured Change from baseline to 8 weeks of treatment (Visit 3), in active and placebo groups.

Publications

Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.

Permalink · PHN.MI's whole pipeline · Catalyst calendar · Every registered study · What changed